Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma

Journal of Dermatological Science

Volumn 52, Issue 1, 2008, Pages 47-54

  Tomimura, Saori ^a   Ogawa, Fumihide ^a   Iwata, Yohei ^a   Komura, Kazuhiro ^a   Hara, Toshihide ^a   Muroi, Eiji ^a   Takenaka, Motoi ^a   Shimizu, Kazuhiro ^a   Hasegawa, Minoru ^b   Fujimoto, Manabu ^b   Sato, Shinichi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Autoantibody; Localized scleroderma; Matrix metalloproteinase 1

Indexed keywords

AUTOANTIBODY; COLLAGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERSTITIAL COLLAGENASE; NUCLEOSOME AUTOANTIBODY; SINGLE STRANDED DEOXYRIBONUCLEIC ACID ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; LINEAR SCLERODERMA; LOCALIZED SCLERODERMA; MALE; MORPHEA; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; RECOMBINANT PROTEINS; SCLERODERMA, LOCALIZED;

EID: 49949087776     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.04.013     Document Type: Article

References (25)

1. Jablonska S., and Rodnan G.P. Localized forms of scleroderma. Clin Rheum Dis 5 (1979) 215-241
2. Sato S., Fujimoto M., Ihn H., et al. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31 (1994) 567-571
3. Falanga V., Medsger Jr. T.A., and Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 123 (1987) 350-353
4. Sato S., Ihn H., Soma Y., et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36 (1993) 1137-1141
5. Ruffatti A., Peserico A., Glorioso S., et al. Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 15 (1986) 637-642
6. Falanga V., Medsger Jr. T.A., Reichlin M., et al. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104 (1986) 849-857
7. Sato S., Kodera M., Hasegawa M., et al. Antinucleosome antibody is a major autoantibody in localized scleroderma. Br J Dermatol 151 (2004) 1182-1188
8. Hayakawa I., Hasegawa M., Takehara K., et al. Anti-DNA topoisomerase IIα autoantibodies in localized scleroderma. Arthritis Rheum 50 (2004) 227-232
9. Nagai M., Hasegawa M., Takehara K., et al. Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma. J Invest Dermatol 122 (2004) 594-601
10. Sato S., Fujimoto M., Hasegawa M., et al. Anti-phospholipid antibody in localized scleroderma. Ann Rheum Dis 62 (2003) 771-774
11. Jimenez S.A., Hitraya E., and Varga J. Pathogenesis of scleroderma: collagen. Rheum Dis Clin Nor Am 22 (1996) 647-674
12. Vuorio T., Makela J.K., Kahari V.M., et al. Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res 279 (1987) 154-160
13. Kahari V.M., Sandberg M., Kalimo H., et al. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol 90 (1988) 664-670
14. Kahari V.M., and Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 6 (1997) 199-213
15. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494
16. Sato S., Hayakawa I., Hasegawa M., et al. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatol 120 (2003) 542-547
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23 (1980) 581-590
18. Krieg T., Braun-Falco O., Perlish J.S., et al. Collagen synthesis in generalized morphea. Arch Dermatol Res 275 (1983) 393-396
19. Takeda K., Hatamochi A., Ueki H., et al. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 103 (1994) 359-363
20. Asano Y., Ihn H., Jinnin M., et al. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. J Invest Dermatol 126 (2006) 1761-1769
21. El-Mofty M., Mostafa W., Esmat S., et al. Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study. Photodermatol Photoimmunol Photomed 20 (2004) 93-100
22. Okano Y. Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 22 (1996) 709-735
23. Komocsi A., Tovari E., Kovacs J., et al. Physical injury as a provoking factor in three patients with scleroderma. Clin Exp Rheumatol 18 (2000) 622-624
24. Trattner A., Figer A., David M., et al. Circumscribed scleroderma induced by postlumpectomy radiation therapy. Cancer 68 (1991) 2131-2133
25. Aiba-Kojima E., Tsuno N.H., Inoue K., et al. Characterization of wound drainage fluids as a source of soluble factors associated with wound healing: comparison with platelet-rich plasma and potential use in cell culture. Wound Repair Regen 15 (2007) 511-520